Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OESTERR KNOPF und METALLWARENF
Original Assignee
OESTERR KNOPF und METALLWARENF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OESTERR KNOPF und METALLWARENFfiledCriticalOESTERR KNOPF und METALLWARENF
Publication of DE1669572UpublicationCriticalpatent/DE1669572U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Description
mit abuebm&zeasind sisd es it SaBSef-M&sy ba&aßEsaf sL es eäes sssaerdan azann-,al-a zmu= v4mud4ttM&'a$ß s. Sdissag aa-ge Js s-y=updia nuhe-4te diesss sijs$ as f ssbtaltzt lind auf-. less= eiwia zuie da-, S' ? p6gs ieee aeaa-&ie . s-äialssg. dee Mrs stst&t atesasa s s&t&fbails-st. !. sov-. ssi'ss el@a. entsTes &iEmfsz% as& f nes-, der ei-siS8& a. <f7X8-2ab-Irkt'it der zu"einti ehtung voia nacholi. e tassstgt as SeBBSfeLes s&g e Iste&teesit de ss-BiE'a's . yesasceälteB saesa<s a s'S$le g@ns& &Me&tsM'M @ S@-& a @Mf Bssgm&S. s es's sz, ostent. «tieue 3 eite.» AlLtmd* = r-ateren&sa ia M 4 sdsI' g m Ee @ f-gs :&4jLaB [is$ Ss 4 saes § s&f a&Si. tes'. . smus as iüoo elo tue ; am : uvrr-sn, atgtieadee, m m gag 4 ein einzoltieaenav mr =tere-Z-ade dezFiiuhreo 1 lot* r » t- lnaear=a dea 3 blo"4v"k2atz von-3ulre-4-ttret ei-unggUt-s 5*SZZG-WeanGes der-j--ise . , r-. eimtbar -liteob-U. Lasea 4BS Se-sedes stltg sns eia fSr ssM a. i, i8. ie. ämm M. sts? MSs. & es Seälias. sit sss da 9IiiWe ! fr'J. e-. at$1nf. f W1i'Gßet &1 ! d~.'/ with abuebm & zea are sisd it with SaBSef- M & sy ba & aßEsaf sL es eäes sss aerdan azann-, al-a zmu = v4mud4tt M &'a $ ß s. Sdissag aa- ge J s s- y = up dia nuhe-4th die sss sijs $ as f ss flashes up gently. less = eiwia zuie da-, S '? p6gs i eee aeaa- & ie. s-äialssg. dee mrs stst & t a tesasa s s & t & fbails-st. ! so V-. ssi'ss el @ a. ent Tes & iEmfsz% as & f nes-, der ei-siS8 & a. <f 7X8-2ab-Irkt'it der zu "Einti ehtung voia nacholi . e tassstgt as SeBBSfeLes s & g e Iste & te esit de ss-BiE'a's. yesasceälteB saes a <sa s' S $ le g @ ns && M e &tsM'M @ S @ - & at the f Bss gm & S. s it s z, ostent. « three sides. »AlLtmd * = r-ateren & sa ia M 4 sdsI 'gm E. e @ f-gs: & 4jLaB [is $ Ss 4 s aes § s & f a & Si. tes'. . s must s as i üoo elo do; am: uvrr-sn, atgti eadee, mm gag 4 ein Einsoltie aenav mr = tere-Z-ade dec Fiiuhreo 1 lot * r »t- lnaear = a dea 3 blo" 4v " k2atz von-3ulre-4-step ungg Ut-s 5 * SZZG-WeanGes der- j - ise. , r-. emmittable -lit eob-U. L. asea 4BS Se-sedes stltg sns eia fSr ssM a. i, i8. ie. umm sts ? MSs. & it Seälias. sit sss there 9 IiiWe! fr'J. e-. at $ 1nf. f W1i'Gßet & 1! d ~. '/
Claims (1)
9*Uat 0*9 » » x zu h #-Z
1 Z% * zu$etwaHg&sjasJa .. - t'. t Mf - è1h ide 8- tuajassiMgMaa <3ssae&s<.Mg »4 sSs&aLJas s & & 4 e {e sb tvtm des,. >eu d »-esss-assQss sasMiSsHesa ms& a& a&ssBsttittMOh1ZQUUe$ S11t'&-8blttng VCU anedUéwsb$ch11. eDar ia ; . sja
.$ < ) 6 4t -St.x & &&,
9 * Uat 0 * 9 »» x to h # -Z
1 line % * to $ approximately Hg & sjas Yes .. - t '. t Mf - è1h ide 8- tua jassiMgMaa <3ssae & s <. M. g » 4 sSs & aLJas s && 4 e {e sb tv tm des ,. > eu d »- esss-assQss sa sMi SsHesa ms & a & a & ssBst tittMOh1ZQUUe $ S11t '& - 8blttng VCU anedUéw sb $ ch11. eDar i a; . sja
. $ <) 6 4 t - St. x && &,
DEO2015U1953-06-261953-10-29
PYROPHORIC LIGHTER WITH DETACHABLE FUEL CONTAINER.
ExpiredDE1669572U
(en)
KIR3DL1-negative CD8 T cells and KIR3DL1-negative natural killer cells contribute to the advantageous control of early human immunodeficiency virus type 1 infection in HLA-B Bw4 homozygous individuals
Cyclosporin-A inhibits IL-2 production by all human T-cell clones having this function, independent of the T4T8 phenotype or the coexpression of cytolytic activity